Rheumatoid Arthritis (RA) is a chronic systemic autoimmune disease that primarily affects the lining of the synovial joints and is associated with progressive disability, premature death, and socioeconomic burdens. The aim of the study was to evaluate the clinical efficacy and safety of glucosamine phosphate, methylsulfonylmethane (MSM), Vitamin C, Curcuma, in the management of Rheumatoid Arthritis. All those patients fulfilling the inclusion criteria presenting with Rheumatoid Arthritis to emergency department or to the out-patient department of general medicine were enrolled in the study. It included 180 adult patients with Rheumatoid Arthritis of both the sexes. All the participants were evaluated by detailed history, clinical examination and severity assessment. Cases were excluded if there was insufficient clinical information to permit allocation of a priority level at diagnosis. Patients aged 25 years or above referred or diagnosed with Rheumatoid Arthritis at our outpatient clinic were included in the study. All together 180 patients were participated in this study, and the response was 100%. All families were approached. Glucosamine sulfate might provide some pain relief for people with Rheumatoid Arthritis. Glucosamine has been found to have positive effects on pain treatment & Relieving pain and improving physical function. MSM may help to relieve joint soreness, stiffness and swelling. MSM is to decrease joint or muscle pain. Collagen peptide significantly reducing pain and joint inflammation.

Author Name: Dr. Sampoorna, Madugula Mahender, S. Vijaya Bhavani & Bhavya Krishna Ponnakanti

URL: View PDF

Keywords: Rheumatoid Arthritis, Early Treatment, Inflammatory Disorder, Joints.

ISSN: 2581-5059

EISSN: 2581-5059

EOI/DOI: 10.46382/MJBAS.2020.4204

Add Citation Views: 1

---